Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism

Clinical Endocrinology

Volumn 74, Issue 2, 2011, Pages 174-180

  Persson, Anita ^a   Bollerslev, Jens ^b   Rosen, Thord ^a   Mollerup, Charlotte L ^c   Franco, Celina ^a   Isaksen, Gunhild A ^b   Ueland, Thor ^b   Jansson, Svante ^a   Caidahl, Kenneth ^a,d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c Rigshospitalet   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HUMAN; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; CALCIUM; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE;

EID: 78651300697     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03909.x     Document Type: Article

References (33)

1. NIH conference. (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Annals of Internal Medicine, 114, 593-597.
2. Bilezikian, J.P., Potts Jr, J.T., Fuleihan, G., et al. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. Journal of Clinical Endocrinology and Metabolism, 87, 5353-5361. (Pubitemid 36034328)
3. Bilezikian, J.P., Khan, A.A., &, Potts Jr, J.T., (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. Journal of Clinical Endocrinology and Metabolism, 94, 335-339.
4. Leifsson, B.G., &, Ahren, B., (1996) Serum calcium and survival in a large health screening program. Journal of Clinical Endocrinology and Metabolism, 81, 2149-2153.
5. Vestergaard, P., &, Mosekilde, L., (2003) Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ, 327, 530-534.
6. Vestergaard, P., Mollerup, C.L., Frokjaer, V.G., et al. (2003) Cardiovascular events before and after surgery for primary hyperparathyroidism. World Journal of Surgery, 27, 216-222.
7. Wermers, R.A., Khosla, S., Atkinson, E.J., et al. (1998) Survival after the diagnosis of hyperparathyroidism: a population-based study. American Journal of Medicine, 104, 115-122.
8. Bollerslev, J., Rosen, T., Mollerup, C.L., et al. (2009) Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 94, 2255-2261.
9. Delfini, E., Petramala, L., Caliumi, C., et al. (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism, 56, 30-36.
10. Fallo, F., Cella, G., Casonato, A., et al. (2006) Biochemical markers of endothelial activation in primary hyperparathyroidism. Hormone and Metabolic Research, 38, 125-129.
11. Lakatos, P., Tatrai, A., Foldes, J., et al. (1996) Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism. Calcified Tissue International, 58, 70-71.
12. Nilsson, I.L., Aberg, J., Rastad, J., et al. (1999) Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery, 126, 1049-1055.
13. Nilsson, I.L., Aberg, J., Rastad, J., et al. (2005) Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery, 137, 632-638.
14. Ogard, C.G., Engelmann, M.D., Kistorp, C., et al. (2005) Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clinical Endocrinology, 63, 493-498.
15. Silverberg, S.J., Lewiecki, E.M., Mosekilde, L., et al. (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism, 94, 351-365.
16. Lundgren, E., Rastad, J., Thrufjell, E., et al. (1997) Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery, 121, 287-294.
17. Siilin, H., Rastad, J., Ljunggren, O., et al. (2008) Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity. Journal of Clinical Endocrinology and Metabolism, 93, 47-53.
18. Rubin, M.R., Maurer, M.S., McMahon, D.J., et al. (2005) Arterial stiffness in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 90, 3326-3330.
19. Rydberg, E., Birgander, M., Bondeson, A.G., et al. (2010) Effect of successful parathyroidectomy on 24-hour ambulatory blood pressure in patients with primary hyperparathyroidism. International Journal of Cardiology, 142, 15-21.
20. Almqvist, E.G., Bondeson, A.G., Bondeson, L., et al. (2002) Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery, 132, 1126-1132.
21. Nilsson, I.L., Aberg, J., Rastad, J., et al. (2000) Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery, 128, 895-902.
22. Piovesan, A., Molineri, N., Casasso, F., et al. (1999) Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clinical Endocrinology, 50, 321-328.
23. Walker, M.D., Fleischer, J.B., Di Tullio, M.R., et al. (2010) Cardiac structure and diastolic function in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 95, 2172-2179.
24. Bollerslev, J., Jansson, S., Mollerup, C.L., et al. (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. Journal of Clinical Endocrinology and Metabolism, 92, 1687-1692.
25. Bollerslev, J., Ueland, T., Jorgensen, A.P., et al. (2006) Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency. European Journal of Endocrinology, 154, 537-543.
26. Schiller, N.B., Shah, P.M., Crawford, M., et al. (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Journal of the American Society of Echocardiography, 2, 358-367.
27. Bolland, M.J., Grey, A.B., Gamble, G.D., et al. (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 90, 1525-1530.
28. Farahnak, P., Ring, M., Caidahl, K., et al. (2010) Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. European Journal of Endocrinology, 163, 461-467.
29. Fitzpatrick, L.A., Bilezikian, J.P., &, Silverberg, S.J., (2008) Parathyroid hormone and the cardiovascular system. Current Osteoporosis Reports, 6, 77-83.
30. Hagstrom, E., Hellman, P., Larsson, T.E., et al. (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation, 119, 2765-2771.
31. Barletta, G., De Feo, M.L., Del, B.R., et al. (2000) Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 85, 1815-1821.
32. Virdis, A., Cetani, F., Giannarelli, C., et al. (2010) The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment. Journal of Clinical Endocrinology and Metabolism, 95, 920-927.
33. Ogino, K., Burkhoff, D., &, Bilezikian, J.P., (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology, 136, 3024-3030.